CRISPR and HIV

A recent study reports the first ever application of base editing to protect immune cells against HIV infection. This is achieved without introducing...

Researchers at Texas Biomedical Research Institute in San Antonio, Texas have developed a novel strategy to inhibit human immunodeficiency virus (HIV)...

In 2021, we've seen positive clinical data for the first ever in vivo CRISPR medicines, base editors are heading for the clinic, and CRISPR therapies...

This week, we look at a CRISPR-based therapy for HIV that has just passed the IND approval stage, and will soon be tested in a Phase 1/2 clinical...

Results from the first clinical trials using CRISPR in persons have been reported. The early first attempts showed safety and feasibility but did not...